Introduction of infection control measures to reduce infection associated with implantable pain therapy devices

Pain Practice

Volumn 7, Issue 3, 2007, Pages 279-284

  Burgher, Abram H ^a   Barnett, Crawford F ^a   Obray, Jon B ^a   Mauck, W David ^a  

^a MAYO CLINIC   (United States)

Author keywords

Complications; Implantable pain therapy; Infection; Infection control; Intrathecal drug delivery; Pain; Pain procedures; Spinal cord stimulation

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; CEFAZOLIN; CHLORHEXIDINE; POVIDONE IODINE;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE INFECTION; DRUG DELIVERY SYSTEM; HUMAN; INCIDENCE; INFECTION COMPLICATION; INFECTION CONTROL; MEDICAL DOCUMENTATION; RETROSPECTIVE STUDY; SAFETY; SPINAL CORD STIMULATION; STATISTICAL SIGNIFICANCE;

ADULT; ANALGESIA; COMMUNICABLE DISEASE CONTROL; CROSS INFECTION; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; INFECTION CONTROL; INFUSION PUMPS, IMPLANTABLE; MALE; MIDDLE AGED; PAIN;

EID: 34548076899     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2007.00142.x     Document Type: Article

References (20)

1. Shealy CN, Mortimer JT, Reswick JB. Electrical inhibition of pain by stimulation of the dorsal columns: Preliminary clinical report. Anesth Analg. 1967; 45: 489-499.
2. Van Buyten J-P, Van Zundert P, Vueghs P, Vanduffel L. Efficacy of spinal cord stimulation: 10 years of experience in a pain centre in Belgium. Eur J Pain. 2001; 5: 299-307.
3. North RB, Kidd DH, Olin J, et al. Spinal cord stimulation for axial low back pain: A prospective, controlled trial comparing dual with single percutaneous electrodes. Spine. 2005; 30: 1412-1418.
4. Hautvast RWM, DeJonste MJL, Staal MJ, et al. Spinal cord stimulation in chronic intractable angina pectoris: A randomized controlled efficacy study. Am Heart J. 1998; 136: 1114-1120.
5. Amann W, Berg P, Gersbach PA, et al. Spinal cord stimulation in the treatment of non-reconstructible stable critical leg ischemia: results of the European Peripheral Vascular disease outcome study (SCS-EPOS). Eur J Vasc Endovasc Surg. 2003; 26: 280-286.
6. Harke H, Gretenkort P, Ladleif HU, Rahman S. Spinal cord stimulation in sympathetically maintained complex regional pain syndrome type I with severe disability. A prospective clinical study. Eur J Pain. 2005; 9: 365-373.
7. Wang JK, Nauss LA, Thomas JE. Pain relief by intrathecally applied morphine in man. Anesthesiology. 1979; 50: 149-151.
8. Follett KA, Boortz-Marx RL, Drake JM, et al. Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology. 2004; 100: 1582-1594.
9. Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain. 1999; 79: 1-13.
10. Ubbink DT, Vermeulen H, Spincemaille GH, et al. Systematic review and meta-analysis of controlled trials assessing spinal cord stimulation for inoperable critical leg ischemia. Br J Surg. 2004; 91: 948-955.
11. Spincemaille GH, Klomp HM, Steyerberg EW, et al. Technical data and complications of spinal cord stimulation: Data from a randomized trial on critical limb ischemia. Stereotact Funct Neurosurg. 2000; 74: 63-72.
12. Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002; 20: 4040-4049.
13. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol. 1999; 20: 247-278.
14. Geubbels EL, Nagelkerke NJ, Mintjes-De Groot AJ, et al. Reduced risk of surgical site infections through surveillance in a network. Int J Qual Health Care. 2006; 18: 127-133.
15. Baker OG. Process surveillance: An epidemiologic challenge for all health care organizations. Am J Infect Control. 1997; 25: 96-101.
16. Lawhorne JD. Implementation of a documentation system of evidence-based processes for the insertion of central venous catheters. Am J Infect Control. 2006; 34: E120.
17. Young EM, Commiskey ML, Wilson SJ. Translating evidence into practice to prevent central venous catheter-associated bloodstream infections: A systems-based intervention. Am J Infect Control. 2006; 34: 503-506.
18. Schweon S, Matika K, Carmona A, et al. A multidisciplinary approach with reducing cardiac surgical site infections. Am J Infect Control. 2006; 34: E138-E139.
19. Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992; 326: 281-286.
20. Barwolff S, Sohr D, Geffers C, et al. Reduction of surgical site infections after caesarean delivery using surveillance. J Hosp Infect. 2006; 64: 156-161.